PerkinElmer Elects Frank Witney to Board of Directors
WALTHAM, Mass.–(BUSINESS WIRE)– PerkinElmer, Inc. (NYSE:PKI), a global leader focused on improving the health and safety of people and the environment, today announced that Frank Witney, Ph.D., has been elected to the Company’s Board of Directors.
“I am delighted to welcome Frank to PerkinElmer’s Board, as he brings deep market knowledge and over 30 years of leadership experience across the life sciences, diagnostics and analytical instruments industry,” said Robert Friel, Chairman and Chief Executive Officer, PerkinElmer.
Most recently, Dr. Witney served as President and Chief Executive Officer of Affymetrix, Inc. (now part of Thermo Fisher Scientific), which specialized in microarray technology and cellular analysis. Previously, Dr. Witney was President and Chief Executive Officer of Dionex Corp., a market leading ion and high performance liquid chromatography company. Prior to that, Dr. Witney first joined Affymetrix when it acquiredPanomics Inc., a quantitative biology company, which he

